Navin R. Pinto
Impact in
Papers in
- Co-authors
- Susan Lerner Cohn (14 shared papers)Julie R. Park (14 shared papers)Wendy B. London (7 shared papers)Mark A. Applebaum (8 shared papers)Samuel L. Volchenboum (6 shared papers)Andrew D.J. Pearson (2 shared papers)Mary Eileen Dolan (1 shared paper)Katherine K. Matthay (2 shared papers)
- Journals
- Pediatric Blood & Cancer (13 papers)Journal of Clinical Oncology (6 papers)Nature Medicine (4 papers)JCO Precision Oncology (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Navin R. Pinto
57 papers receiving 2.9k citations
Navin R. Pinto's Hit Papers
Peers
Comparison fields: 5 of 91
- Neurology 1.3k
- Oncology 1.0k
- Cancer Research 516
- Genetics 261
- Immunology 260
Countries citing papers authored by Navin R. Pinto
This map shows the geographic impact of Navin R. Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Navin R. Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Navin R. Pinto more than expected).
Fields of papers citing papers by Navin R. Pinto
This network shows the impact of papers produced by Navin R. Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Navin R. Pinto. The network helps show where Navin R. Pinto may publish in the future.
Co-authors
The 25 scholars most cited alongside Navin R. Pinto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Advances in Risk Classification and Treatment Strategies for Neuroblastoma Hit paper breakdown → | 2015 | 698 |
| 2 | Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial Hit paper breakdown → | 2019 | 265 |
| 3 | Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis Hit paper breakdown → | 2021 | 252 |
| 4 | Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety Hit paper breakdown → | 2022 | 204 |
| 5 | 2018 | 137 | |
| 6 | 2010 | 120 | |
| 7 | 2011 | 114 | |
| 8 | 2023 | 89 | |
| 9 | 2018 | 82 | |
| 10 | 2009 | 76 | |
| 11 | Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial Hit paper breakdown → | 2025 | 75 |
| 12 | 2019 | 63 | |
| 13 | 2016 | 62 | |
| 14 | 2021 | 60 | |
| 15 | 2016 | 58 | |
| 16 | 2014 | 55 | |
| 17 | 2017 | 50 | |
| 18 | 2020 | 50 | |
| 19 | 2022 | 48 | |
| 20 | 2022 | 36 |
About Navin R. Pinto
Navin R. Pinto is a scholar working on Neurology, Oncology, Pediatrics, Perinatology and Child Health, Genetics and Pulmonary and Respiratory Medicine, having authored 61 papers that have together received 3.0k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (32 papers), CAR-T cell therapy research (11 papers), Sarcoma Diagnosis and Treatment (6 papers), Acute Lymphoblastic Leukemia research (4 papers), Lung Cancer Research Studies (3 papers), Glioma Diagnosis and Treatment (3 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Neurology (1.3k citations), Oncology (1.0k citations), Cancer Research (516 citations), Genetics (261 citations) and Immunology (260 citations). Navin R. Pinto has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Susan Lerner Cohn, Julie R. Park, Wendy B. London, Mark A. Applebaum, Samuel L. Volchenboum, Andrew D.J. Pearson, Mary Eileen Dolan, Katherine K. Matthay, Gudrun Schleiermacher and Dominique Valteau‐Couanet. Their work appears in journals such as Pediatric Blood & Cancer, Journal of Clinical Oncology, Nature Medicine, JCO Precision Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.